Glycolic Peel Enhances Azelaic Acid in Melasma Treatment

This article originally appeared here.
Share this content:
Glycolic Peel Enhances Azelaic Acid in Melasma Treatment
Glycolic Peel Enhances Azelaic Acid in Melasma Treatment

FRIDAY, Aug. 19, 2016 (HealthDay News) -- Glycolic acid (GA) peel enhances the therapeutic efficacy of topical azelaic acid (AA) cream for treatment of melasma, according to a study published online Aug. 8 in the Journal of Cosmetic Dermatology.

Surabhi Dayal, M.D., from the Sharma Post Graduate Institute of Medical Sciences in Rohtak, India, and colleagues assessed the clinical efficacy and safety of glycolic peel in conjunction with topical AA for treatment of melasma. Over 24 weeks, 60 patients received either serial GA peel every three weeks with twice-daily 20 percent AA cream or only 20 percent AA cream (control group).

The researchers found that improvement in Melasma Area Severity Index (MASI) and percentage decrease in MASI scoring were statistically significant 12 weeks and beyond in the study group versus the control group. There was also a significant improvement in melasma quality of life scores after treatment in the study group versus the control group. Both groups had minor reversible side effects, which did not require cessation of therapy.

"GA peel enhances therapeutic efficacy of topical AA cream for treatment of melasma, with improvement in quality of life without serious side effects," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Illicit Marijuana Use Up in States With Legal Medical Use

Illicit Marijuana Use Up in States With Legal ...

Cannabis use disorder is also rising faster in states with legalization laws

Chromosome Instability Test Prognostic in NSCLC

Chromosome Instability Test Prognostic in NSCLC

Chromosome instability associated with higher risk of relapse, death within 2 years

CDC: Opioid-Related Mortality Rate Might Be Underestimated

CDC: Opioid-Related Mortality Rate Might Be Underestimated

Death certificates from drug-linked infections may not label opioids as possible cause

is free, fast, and customized just for you!

Already a member?

Sign In Now »